Stock brief · the live tape
AVIRAtea Pharmaceuticals, Inc.
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · Nasdaq
close Friday, October 30, 2026
No member of Congress has disclosed a trade in this ticker.
130 insider filings · 2 tracked funds
See what the activity adds up to.
Unlock the CAT Scan.
The score, what drives it, and who is behind it.
Go ProAlready on Pro? Sign inThe tape
Price with a twin dot per disclosed trade: filled at the trade, hollow at the filing. The dashed gap is what the market did in between, not anyone’s return.
The boardroom
Scheduled 10b5-1 sales are usually noise, set on autopilot months ago. The unscheduled ones are the ones to read.
The fund book
Tracked 13F holders, valued at the 30 Jun 2026 quarter end, and how each position moved from the quarter before.
Positions as filed for the quarter ending 30 Jun 2026, the latest on file. A 13F is a quarter-end photograph filed up to 45 days later, so this is where these funds stood then, not what they hold now. Common stock only: options and short positions are not in a 13F, and a fund that had already sold out does not appear.
⚠️ Public information, sourced from STOCK Act, Form 4 and 13F filings. Ranges use midpoints. Price paths between a trade and its filing are market moves, not anyone’s return. Not financial advice.